Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma

被引：0
|
作者：
Hideki Goto
Shinichi Makita
Koji Kato
Kota Tokushige
Taizo Fujita
Koichi Akashi
Koji Izutsu
Takanori Teshima
机构：
[1] Hokkaido University Faculty of Medicine,Department of Hematology, Graduate School of Medicine
[2] National Cancer Center Hospital,Department of Hematology
[3] Kyushu University Graduate School of Medical Sciences,Department of Medicine and Biosystemic Science
[4] Novartis Pharma K.K.,undefined
来源：
International Journal of Clinical Oncology | 2020年 / 25卷
关键词：
Tisagenlecleucel; CAR T-cell therapy; Diffuse large B-cell lymphoma; JULIET;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1736 / 1743
页数：7
相关论文
共 50 条
  • [21] Efficacy of salvage radiotherapy for relapsed/refractory diffuse large B-cell lymphoma
    Wang, Shu-Bei
    Chen, Jia-Yi
    Zhao, Wei-Li
    Kirova, Youlia M.
    Cao, Wei-Guo
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1019 - 1026
  • [22] Tisagenlecleucel in Diffuse Large B-Cell Lymphoma
    Schwartz, Jonathan D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (16): : 1585 - 1586
  • [23] Clinical Efficacy and Safety in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Literature Review
    Colosia, Ann
    Njue, Annete
    Trask, Peter C.
    Olivares, Robert
    Khan, Shahnaz
    Abbe, Adeline
    Police, Rachel
    Wang, Jianmin
    Ruiz-Soto, Rodrigo
    Kaye, James A.
    Awan, Farrukh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05): : 343 - 355
  • [24] Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia
    Hidefumi Hiramatsu
    Souichi Adachi
    Katsutsugu Umeda
    Itaru Kato
    Lamis Eldjerou
    Andrea Chassot Agostinho
    Kazuto Natsume
    Kota Tokushige
    Yoko Watanabe
    Stephan A. Grupp
    International Journal of Hematology, 2020, 111 : 303 - 310
  • [25] Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia
    Hiramatsu, Hidefumi
    Adachi, Souichi
    Umeda, Katsutsugu
    Kato, Itaru
    Eldjerou, Lamis
    Agostinho, Andrea Chassot
    Natsume, Kazuto
    Tokushige, Kota
    Watanabe, Yoko
    Grupp, Stephan A.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (02) : 303 - 310
  • [26] Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan
    Goto, Hideki
    Kitawaki, Toshio
    Fujii, Nobuharu
    Kato, Koji
    Onishi, Yasushi
    Fukuhara, Noriko
    Yamauchi, Takuji
    Toratani, Kazunori
    Kobayashi, Hiroki
    Yoshida, Shota
    Shimo, Masatoshi
    Onodera, Koichi
    Senjo, Hajime
    Onozawa, Masahiro
    Hirata, Kenji
    Yokota, Isao
    Teshima, Takanori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (06) : 816 - 826
  • [27] Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan
    Hideki Goto
    Toshio Kitawaki
    Nobuharu Fujii
    Koji Kato
    Yasushi Onishi
    Noriko Fukuhara
    Takuji Yamauchi
    Kazunori Toratani
    Hiroki Kobayashi
    Shota Yoshida
    Masatoshi Shimo
    Koichi Onodera
    Hajime Senjo
    Masahiro Onozawa
    Kenji Hirata
    Isao Yokota
    Takanori Teshima
    International Journal of Clinical Oncology, 2023, 28 : 816 - 826
  • [28] Tafasitamab for refractory/relapsed diffuse large B-cell lymphoma
    Lu, Q.
    Huang, H.
    Tang, S.
    Wang, Y.
    Yang, D-H
    DRUGS OF TODAY, 2021, 57 (09) : 571 - 580
  • [29] Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Dickinson, Michael J.
    Carlo-Stella, Carmelo
    Morschhauser, Franck
    Bachy, Emmanuel
    Corradini, Paolo
    Iacoboni, Gloria
    Khan, Cyrus
    Wrobel, Tomasz
    Offner, Fritz
    Wu, Shang-Ju
    Cartron, Guillaume
    Hertzberg, Mark
    Sureda, Anna
    Perez-Callejo, David
    Lundberg, Linda
    Relf, James
    Dixon, Mark
    Clark, Emma
    Humphrey, Kathryn
    Hutchings, Martin
    Trney, Marek
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24): : 2220 - 2231
  • [30] EFFICACY OF AXICABTAGEN CILOLEUCEL VERSUS TISAGENLECLEUCEL IN THE TREATMENT OF RELAPSED OR REFRACTORY DIFFUSE LARGE CELL LYMPHOMA B IN SPAIN
    Mariana, Bastos-Oreiro
    Ana, De las Heras
    Maria, Presa
    Miguel Angel, Casado
    Carlos, Pardo
    Victoria, Martin-Escudero
    Anna, Sureda
    HAEMATOLOGICA, 2021, 106 (10) : 292 - 293
12345